Medicines (Rx)
Highlights
- PG2® Lyo. Injection 500mg
- Used by 134 medical centers and medical institutes (over 90% coverage of medical centers)
- Prescribed by about 500 oncologists
- Taking care of 15,000+ patients
- As of 2021, included in the benefits package of NHI
- Imported into South Korea and Turkey as a special case to meet the needs of patients in the region.
In line with the United Nations’ Sustainable Development Goals (SDGs)
Products Included in the NHI Benefits Package
Around 92% of cancer patients in Taiwan suffer from Cancer-Related Fatigue and PhytoHealth PG2® Injection 500mg is the only new prescription treatment to fight against this disease. Through hard work from the team, PhytoHealth PG2® Injection 500mg has been included in the National Health Insurance Administration (NHI) Benefits Package from March 1, 2010, benefiting breast cancer patients. And we are continuously giving our best to expand the target beneficiary groups to help more cancer patients push through the battle against cancer.
PG2® Injection Included in NHI Benefits Package
According to the regulations of the NHI, PG2® Injection is restricted to stage IV breast cancer patients who experience moderate to severe fatigue due to disease progression.
Designated Patient Medication Project
We understand that in some countries or regions, patients may face difficulties in obtaining appropriate medical treatment. We have a professional team that can assist patients in areas where the product has not yet been marketed to obtain the product as early as possible and obtain the best treatment. If you are facing this situation, please contact us, and we will do our best to assist.
In Turkey
We assist local companies in project procurement with Compassionate Use, allowing PhytoHealth PG2® Injection 500mg to be imported as a special case to meet the medical needs of local patients before its launch in Turkey.
In Korea
We support and cooperate with local companies to import PhytoHealth PG2® Injection 500mg, a special case to South Korea for terminal cancer patients.
High Coverage Rate in Medical Institutions
We are committed to making it easier for more patients suffering from severe Cancer-Related Fatigue to obtain helpful therapeutic drugs. PhytoHealth PG2® Injection 500mg has been used by more than 100 medical centers and medical institutions in Taiwan, and the coverage rate of medical centers have reached 90%. For Phytohealth 47 Nearly 400 oncologists have written prescriptions, and the number is still increasing. Cancer-Related Fatigue patients are now better able to receive proper care.
Number of Hospitals and Clinics Use PhytoHealth PG2® Injection 500mg
Large medical centers
-
18
locations
- over 90% coverage
Regional and district hospitals
-
67
locations
Clinics
-
49
locations
Drug Usage
Prescribing oncologists
- 500physicians
Patients receiving treatment
- 15000patients